COVID Treatment & Management
Sort by:
This Week in Virology (TWiV)
Combatting a Vacuum of Medical Information, Adeno-associated Virus Type 2 in US Children with Acute Severe Hepatitis, and the Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID-19 Symptoms
FEATURING
Daniel Griffin,
Vincent Racaniello
- 15 views
- April 21, 2023
RheumNow
EULAR 2023 Insights: New Thoughts on Long COVID from EULAR 2023
FEATURING
Leonard Calabrese,
John J. Cush
- 8 views
- June 22, 2023
California Orthopaedic Association
COVID Science and Policy in California
FEATURING
Jay Bhattacharya
- 4 views
- July 3, 2023
Icahn School of Medicine at Mount Sinai
Challenges in Internal Medicine: COVID-19 Update
FEATURING
Sean Liu
- 338 views
- August 2, 2023
- 1
This Week in Virology (TWiV)
Effectiveness of Monoclonal Antibodies for Treatment of COVID-19, Efficacy and Safety of Anakinra Plus Standard of Care for Patients with Severe COVID-19, and Defining of Post COVID-19 Condition Among Published Research Studies
FEATURING
Daniel Griffin,
Vincent Racaniello
- 246 views
- August 2, 2023
This Week in Virology (TWiV)
First Respiratory Syncytial Virus (RSV) Vaccine Approved for use in the United States, Comparative Effectiveness of the SARS-COV-2 Vaccines During Delta Dominance, Clinical Outcomes Following Treatment for COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 18 views
- August 2, 2023
MedCram
Vilobelimab for Severe COVID-19: Are There Possible Applications in the Treatment of Other Diseases?
FEATURING
Roger Seheult
- 6 views
- August 2, 2023
California Medical Association
Diagnosis and Management of Neuropsychiatric Symptoms of Long COVID
FEATURING
Helen Lavretsky
- 12 views
- August 2, 2023
This Week in Virology (TWiV)
Variant-Specific Clinical Performance of a SARS-CoV-2 Rapid Antigen Test with Focus on Omicron VOC, Trajectories of the Evolution of Post COVID-19 Condition, and Efficacy of Cognitive Behavioral Therapy Targeting Severe Fatigue Following COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 10 views
- August 2, 2023
This Week in Virology (TWiV)
Potential for Recurrent Monkeypox Outbreaks, Nirmatrelvir/Ritonavir Receiving FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19, Efficacy and Safety of Antimicrobial Stewardship Prospective Audit and Feedback in Patients Hospitalized with COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 9 views
- August 2, 2023
This Week in Virology (TWiV)
Discerning the Role of Children in Household Viral Transmission During the COVID-19 Pandemic, Changing Epidemiology of Adults Hospitalized with COVID-19 After Introduction of Vaccines, and Development of a Definition of Post Acute Sequelae of SARS-CoV-2 Infection
FEATURING
Daniel Griffin,
Vincent Racaniello
- 2 views
- August 2, 2023
MicrobeTV
The Next Wave of Severe COVID-19
FEATURING
Paul Offit,
Vincent Racaniello
- 237 views
- August 2, 2023
- 2
MicrobeTV
Tracking Progress Toward Poliomyelitis Eradication, Evaluation of Oseltamivir to Prevent Hospitalization in Outpatients with Influenza, and Successful Treatment of Persistent Symptomatic COVID-19 Infection with Extended Duration Nirmatrelvir/Ritonavir
FEATURING
Daniel Griffin,
Vincent Racaniello
- 9 views
- August 2, 2023
This Week in Virology (TWiV)
CDC Vaccine Advisory Group Recommends Newly Approved RSV Vaccines, Real-World Effectiveness of Nirmatrelvir/Ritonavir on COVID-19, and COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization
FEATURING
Daniel Griffin,
Vincent Racaniello
- 14 views
- August 2, 2023
This Week in Virology (TWiV)
New Risk Assessment for the H5N1 Avian Flu Viruses, Repeated Antibiotic Exposure and Risk of Hospitalization and Death Following COVID-19 Infection, and Long Term Follow-Up of a Multicenter Cohort of COVID-19 Patients with Pulmonary Embolism
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- August 2, 2023
This Week in Virology (TWiV)
SARS-CoV-2 Reinfection and Severity of the Disease: Effectiveness of COVID-19 Bivalent Vaccine, Molnupiravir and Risk of Post-acute Sequelae of COVID-19, and Low Vitamin D Levels Associated with Long COVID Syndrome in COVID-19 Survivors
FEATURING
Daniel Griffin,
Vincent Racaniello
- 16 views
- August 3, 2023
This Week in Virology (TWiV)
Influenza Hemagglutinin Stem Nanoparticle Vaccine Induces Cross-Group 1 Neutralizing Antibodies in Healthy Adults, Impact of SARS-CoV-2 Variants on Inpatient Clinical Outcome, and Gut Microbiota Derived Symbiotic Formula (SIM01) as a Novel Adjuvant Therapy for COVID‐19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 5 views
- August 3, 2023
This Week in Virology (TWiV)
Advisory Committee Recommendations on Use of RSV Vaccines in Older Adults, Case Report of Leprosy in Central Florida, and the Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients with COVID‐19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 569 views
- August 3, 2023
- 5
Cleveland Clinic Rheumatology
The Changing Landscape of Long COVID
FEATURING
Leonard Calabrese
- 373 views
- August 8, 2023
- 2
Cleveland Clinic Rheumatology
COVID-19 for the Rheumatologist: Breakthrough, Vaccines, and Treatment
FEATURING
Cassandra Calabrese
- 287 views
- August 8, 2023
- 1
Cleveland Clinic Rheumatology
Integrative Health Approaches for Optimum Immune Health
FEATURING
Chenchen Wang
- 140 views
- August 8, 2023
MicrobeTV
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Severe COVID-19 Prevention, Association Between SARS-CoV-2 Positivity and Long COVID Duration, and NIH Launching Phase 2 Long-COVID Treatment Trials
FEATURING
Daniel Griffin,
Vincent Racaniello
- 200 views
- August 9, 2023
- 2